Actively Recruiting
Starting Technology in At Risk Type 1 Diabetes Study
Led by University of California, Los Angeles · Updated on 2026-02-13
40
Participants Needed
3
Research Sites
142 weeks
Total Duration
On this page
Sponsors
U
University of California, Los Angeles
Lead Sponsor
L
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Diabetes technology has revolutionized T1D management, disparities in technology access are evident among racial-ethnic minorities, patients with lower socioeconomic status and those with poorly controlled T1D (A1c\>8.5%). In order to examine whether diabetes technology can reduce diabetes care burdens and enhance outcomes among some of highest need patients, diabetes technology clinical trials must be expanded beyond the very select populations included in studies thus far (ie., mostly White, higher SES). Therefore, the investigators propose to perform a pilot RCT of hybrid closed-loop insulin pump therapy (HCL) in 40 diverse adult patients with poorly controlled T1D (HbA1c \>8.5%) from the largest academic and safety net health systems in the Los Angeles region to determine the feasibility of a RCT in this population and identify facilitators and barriers of effective use of closed loop insulin pump therapy in patients with poorly controlled T1D.
CONDITIONS
Official Title
Starting Technology in At Risk Type 1 Diabetes Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Type 1 Diabetes
- A1c >8.5%
- Not insulin pump user
- Primary language of English or Spanish
- Have medical insurance coverage
You will not qualify if you...
- No measured A1c in the past year
- Have comorbidities that can result in inaccurate hemoglobin A1c
- Have cognitive, physical or mental impairment precluding diabetes technology use
- Limited life expectancy (<1 year)
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
UCLA
Santa Monica, California, United States, 90404
Actively Recruiting
2
Olive View-UCLA Medical Center
Sylmar, California, United States, 91342
Actively Recruiting
3
Harbor-UCLA Medical Center
Torrance, California, United States, 90502
Actively Recruiting
Research Team
E
Estelle M Everett, MD, MHS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here